1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
-
Mark
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
(
- Contribution to journal › Article
-
Mark
Sex differences in oncogenic mutational processes
(
- Contribution to journal › Article
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
- 2019
-
Mark
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article
- 2018
-
Mark
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
2018) In Annals of Oncology(
- Contribution to journal › Article
- 2017
-
Mark
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
(
- Contribution to journal › Article
-
Mark
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
(
- Contribution to journal › Article